Richard Slansky
2018 - OncoSec Medical
In 2018, Richard Slansky earned a total compensation of $915K as Former Chief Financial Officer at OncoSec Medical, a 76% increase compared to previous year.
Compensation breakdown
| Bonus | $120,000 |
|---|---|
| Option Awards | $180,000 |
| Salary | $300,000 |
| Other | $315,014 |
| Total | $915,014 |
Slansky received $315K in other compensation, accounting for 34% of the total pay in 2018.
Slansky also received $120K in bonus, $180K in option awards and $300K in salary.
Rankings
In 2018, Richard Slansky's compensation ranked 9,630th out of 14,244 executives tracked by ExecPay. In other words, Slansky earned more than 32.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,630 out of 14,244 | 32nd |
Division Manufacturing | 3,870 out of 5,759 | 33rd |
Major group Chemicals And Allied Products | 1,459 out of 2,122 | 31st |
Industry group Drugs | 1,229 out of 1,811 | 32nd |
Industry Pharmaceutical Preparations | 947 out of 1,385 | 32nd |
Source: SEC filing on November 8, 2018.
Slansky's colleagues
We found three more compensation records of executives who worked with Richard Slansky at OncoSec Medical in 2018.